1. 29th Congress of the European Society of Cardiology

   •    

   Preface Pages: 1 - 1

2. Hot line 1

   • J. P. Ottervanger

   Hot lines Pages: 2 - 3

3. Hot line II

   • H. M. Nathoe

   Hot lines Pages: 4 - 5

4. Hot line III

   • A. J. Teske
   • J. S. S. G. de Jong

   Hot lines Pages: 6 - 7

5. Clinical trial update I

   • P. G. Postema

   Clinical trial updates Pages: 8 - 9

6. Clinical trial update II

   • E. E. van der Wall

   Clinical trial updates Pages: 10 - 11

7. Past, present and future of ACE inhibitors

   • S. G. Molhoek

   Satellite symposia Pages: 12 - 13

8. The bridge to achieving the greater LDL-C goal of <70 mg/dl: inhibiting cholesterol absorption and production

   • A. H. E. M. Maas

   Satellite symposia Pages: 14 - 14

9. The future of interventional therapy in cardiology

   • L. F. Tops

   Satellite symposia Pages: 15 - 16

10. Echocardiography: a new window for the heart

    • N. Marsan Ajmone

    Satellite symposia Pages: 17 - 18

11. I^f inhibition: the new strategy in cardiovascular risk management

    • I. R. Henkens

    Satellite symposia Pages: 19 - 20

12. Setting the standard in pulmonary hypertension management

    • S. G. Molhoek
    • H. W. Vliegen

    Satellite symposia Pages: 21 - 22

13. New evidence in the management of cardiovascular risk: the place of heart rate

    • D. A. Pijnappels

    Satellite symposia Pages: 23 - 24

14. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

    • M. V. Huisman

    Satellite symposia Pages: 25 - 27

15. Innovative device technologies for optimised heart failure management

    • J. A. Kragten

    Satellite symposia Pages: 28 - 29

16. Highlight session

    • C. Ypenburg

    Highlight session Pages: 30 - 35